We are live on
!
Find out more
BFO
Boston Family Office Portfolio holdings
AUM
$1.5B
1-Year Est. Return
11.68%
This Fund
S&P 500
This Quarter
Est. Return
+4.97%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$731M
AUM Growth
+$12.7M
(+1.8%)
Cap. Flow
-$14.8M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
21.42%
Holding
248
New
14
Increased
60
Reduced
107
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$2.96M |
| 2 |
Hubbell
HUBB
|
+$1.35M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$1.34M |
| 4 |
Kinder Morgan
KMI
|
+$993K |
| 5 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$984K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$5.22M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.43M |
| 3 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$1.47M |
| 4 |
iShares MSCI Thailand ETF
THD
|
+$1.24M |
| 5 |
Teradata
TDC
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.65% |
| 2 | Industrials | 14.35% |
| 3 | Technology | 11.94% |
| 4 | Consumer Staples | 10.97% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$771B
| $18.5M | 2.54% |
90,946
-11,823
| -12% | -$2.43M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $18.1M | 2.48% |
151,071
-544
| -0.4% | -$62.9K |
|
3
Gilead Sciences
GILD
$165B
| $17.8M | 2.43% |
175,631
-1,597
| -0.9% | -$166K |
|
4
Johnson & Johnson
JNJ
$640B
| $17.4M | 2.38% |
169,609
-368
| -0.2% | -$37K |
|
|
SRCL
5
DELISTED
Stericycle Inc
SRCL
| $16.8M | 2.3% |
139,092
+10,505
| +8% | +$1.34M |
|
|
ANSS
6
DELISTED
Ansys
ANSS
| $15.9M | 2.18% |
172,024
+1,025
| +0.6% | +$94.6K |
|
7
ExxonMobil
XOM
$650B
| $14.3M | 1.96% |
183,903
-185
| -0.1% | -$14.8K |
|
8
Middleby
MIDD
$6.01B
| $12.9M | 1.76% |
119,258
-1,350
| -1% | -$150K |
|
|
9
Vanguard FTSE Emerging Markets ETF
VWO
$117B
| $12.7M | 1.73% |
387,249
-151,717
| -28% | -$5.22M |
|
10
General Mills
GIS
$20.2B
| $12.1M | 1.66% |
210,422
-8,769
| -4% | -$504K |
|
11
American Tower
AMT
$83.5B
| $11.7M | 1.6% |
120,687
+1,290
| +1% | +$126K |
|
12
Procter & Gamble
PG
$340B
| $11.7M | 1.6% |
147,293
-3,207
| -2% | -$245K |
|
13
Apple
AAPL
$4.97T
| $11.5M | 1.58% |
438,716
+4,372
| +1% | +$125K |
|
14
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
| $11.5M | 1.57% |
45,119
-2,530
| -5% | -$658K |
|
15
Union Pacific
UNP
$174B
| $11M | 1.5% |
140,574
+1,147
| +0.8% | +$98.4K |
|
16
Nike
NKE
$64.1B
| $10.9M | 1.49% |
174,073
+5,115
| +3% | +$330K |
|
17
GE Aerospace
GE
$364B
| $10.3M | 1.41% |
68,862
-2,607
| -4% | -$370K |
|
|
MRSH
18
Marsh
MRSH
$94.3B
| $9.73M | 1.33% |
175,488
-11,070
| -6% | -$610K |
|
19
AptarGroup
ATR
$8.69B
| $9.71M | 1.33% |
133,609
-635
| -0.5% | -$45.9K |
|
20
iShares Core S&P Small-Cap ETF
IJR
$109B
| $9.7M | 1.33% |
176,236
-9,226
| -5% | -$520K |
|
21
Oracle
ORCL
$339B
| $9.31M | 1.27% |
254,826
-300
| -0.1% | -$11.5K |
|
22
SLB Ltd
SLB
$72.7B
| $9.19M | 1.26% |
131,806
+790
| +0.6% | +$59.2K |
|
23
Rockwell Automation
ROK
$51.1B
| $9.12M | 1.25% |
88,859
-5,500
| -6% | -$577K |
|
24
Berkshire Hathaway Class B
BRK.B
$1.1T
| $8.96M | 1.23% |
67,819
-466
| -0.7% | -$62.5K |
|
25
Ecolab
ECL
$79.8B
| $8.92M | 1.22% |
77,947
+825
| +1% | +$97K |
|
Similar funds
CP
JFGLC
AAM
TP
SCM
FMI
NSGL
RCW
Boston Family Office's Q4 2015 Portfolio in Review
As of Q4 2015, Boston Family Office held 248 positions worth $731M, up 1.8% from $718M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Boston Family Office's Q4 2015 filing shows 14 new, 60 increased, 107 reduced and 10 closed positions. Its largest new stake was Hubbell: 13,250 shares worth $1.34M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $5.22M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.
- Boston Family Office's largest Q4 2015 buy was Hubbell: 13,250 shares worth $1.34M.
- Boston Family Office added most to iShares MSCI Emerging Markets ETF in Q4 2015, an estimated $2.96M increase.
- Boston Family Office's biggest Q4 2015 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $5.22M.
- Boston Family Office fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $1.47M.
- Boston Family Office's ten largest holdings make up 21% of its $731M portfolio in Q4 2015.
- Boston Family Office opened 14 new positions and closed 10 in Q4 2015.
- Boston Family Office's portfolio value rose 1.8% quarter-over-quarter to $731M.
Based on Boston Family Office's 13F filing for Q4 2015, filed 4 Feb 2016.